These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 31834886)

  • 1. Do cancer stem cells exist? A pilot study combining a systematic review with the hierarchy-of-hypotheses approach.
    Bartram I; Jeschke JM
    PLoS One; 2019; 14(12):e0225898. PubMed ID: 31834886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer stem cell hypotheses: impact on modern molecular physiology and pharmacology research.
    Pantic I
    J Biosci; 2011 Dec; 36(5):957-61. PubMed ID: 22116294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zebrafish as a model for cancer self-renewal.
    Ignatius MS; Langenau DM
    Zebrafish; 2009 Dec; 6(4):377-87. PubMed ID: 19954344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer stem cell heterogeneity: origin and new perspectives on CSC targeting.
    Eun K; Ham SW; Kim H
    BMB Rep; 2017 Mar; 50(3):117-125. PubMed ID: 27998397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interpretation of interlocking key issues of cancer stem cells in malignant solid tumors.
    Liu WH; You N; Zhang N; Yan HT; Wang T; Huang Z; Liu HB; Tang LJ
    Cell Oncol (Dordr); 2012 Dec; 35(6):397-409. PubMed ID: 23179790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Holistic Approach to Cell Characteristics and Behavioral Analysis.
    Aktug H; Ozdil B; Kocatürk DC; Acikgoz E
    Crit Rev Oncog; 2019; 24(1):21-26. PubMed ID: 31679216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer stem cells: a guide for skeptics.
    Tomasson MH
    J Cell Biochem; 2009 Apr; 106(5):745-9. PubMed ID: 19184979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer Stem Cells.
    Woodward WA; Hill RP
    Recent Results Cancer Res; 2016; 198():25-44. PubMed ID: 27318680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer Stem Cell Hypothesis for Therapeutic Innovation in Clinical Oncology? Taking the Root Out, Not Chopping the Leaf.
    Dzobo K; Senthebane DA; Rowe A; Thomford NE; Mwapagha LM; Al-Awwad N; Dandara C; Parker MI
    OMICS; 2016 Dec; 20(12):681-691. PubMed ID: 27930094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional role of solid tumor stem cells in disease etiology and susceptibility to therapeutic interventions.
    Ramdass B; Duggal R; Minev B; Chowdhary A; Koka P
    J Stem Cells; 2013; 8(3-4):189-231. PubMed ID: 24699025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic.
    Patrawala L; Calhoun T; Schneider-Broussard R; Zhou J; Claypool K; Tang DG
    Cancer Res; 2005 Jul; 65(14):6207-19. PubMed ID: 16024622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer stem cells: an old idea--a paradigm shift.
    Wicha MS; Liu S; Dontu G
    Cancer Res; 2006 Feb; 66(4):1883-90; discussion 1895-6. PubMed ID: 16488983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer stem cell research in Iran: potentials and challenges.
    Roudi R; Ebrahimi M; Shariftabrizi A; Madjd Z
    Future Oncol; 2017 Aug; 13(20):1809-1826. PubMed ID: 28776391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer stem cells: characteristics and their potential role for new therapeutic strategies.
    Bohl SR; Pircher A; Hilbe W
    Onkologie; 2011; 34(5):269-74. PubMed ID: 21577035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer stem cell: fundamental experimental pathological concepts and updates.
    Islam F; Qiao B; Smith RA; Gopalan V; Lam AK
    Exp Mol Pathol; 2015 Apr; 98(2):184-91. PubMed ID: 25659759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into new mechanisms and models of cancer stem cell multidrug resistance.
    Garcia-Mayea Y; Mir C; Masson F; Paciucci R; LLeonart ME
    Semin Cancer Biol; 2020 Feb; 60():166-180. PubMed ID: 31369817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer Stem Cells: Root of the Evil.
    Erkisa M; Karakas D; Ulukaya E
    Crit Rev Oncog; 2019; 24(1):69-87. PubMed ID: 31679222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of Power-Law Growth in the Self-Renewal of Heterogeneous Glioma Stem Cell Populations.
    Sugimori M; Hayakawa Y; Boman BM; Fields JZ; Awaji M; Kozano H; Tamura R; Yamamoto S; Ogata T; Yamada M; Endo S; Kurimoto M; Kuroda S
    PLoS One; 2015; 10(8):e0135760. PubMed ID: 26284929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low adherent cancer cell subpopulations are enriched in tumorigenic and metastatic epithelial-to-mesenchymal transition-induced cancer stem-like cells.
    Morata-Tarifa C; Jiménez G; García MA; Entrena JM; Griñán-Lisón C; Aguilera M; Picon-Ruiz M; Marchal JA
    Sci Rep; 2016 Jan; 6():18772. PubMed ID: 26752044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.